Q1Medicare.com - Latest Medicare News
Out-of-Pocket: TrOOP, RxMOOP, and MOOP

Mar, 18 2025 — If you are enrolled in a Medicare drug plan with Enhanced Alternative (EA) benefits, it is possible that you will pay significantly less than $2,000 out-of-pocket and still reach the annual $2,000 maximum prescription out-of-pocket spending limit or RxMOOP.

Feb, 09 2021 — You exit your Medicare Part D plan's Coverage Gap (or Donut Hole) and enter into the Catastrophic Coverage phase - for the remainder of the plan year (until December 31st) - and the cost of your form . . .

Jan, 20 2020 — What happens after I meet my 2020 Medicare Part D plan's $6,350 TrOOP threshold (total out-of-pocket drug spending limit)? You exit the Coverage Gap (or Donut Hole) and enter into the Catastrophic C . . .

Sep, 29 2016 — The Medicare Advantage plan Maximum Out-of-Pocket (MOOP) threshold limits how much you will spend on co-payments and co-insurance for covered or eligible Medicare Part A (in-patient or hospitalizatio . . .

Oct, 16 2015 — The Medicare Advantage plan Maximum Out-of-Pocket (MOOP) threshold limits how much you will spend on co-payments and co-insurance for covered or eligible Medicare Part A (in-patient or hospitalizatio . . .

May, 09 2015 — This phase of your Medicare Part D coverage is called the Catastrophic Coverage phase and has the same cost-sharing for every Medicare Part D plan.   For generics or preferred brand drugs tha . . .

Oct, 04 2014 — The Maximum Out-of-Pocket (MOOP) Limit for a Medicare Advantage plan caps how much you will spend on co-payments and co-insurance for covered or eligible Medicare Part A (hospitalization) and Part B . . .

May, 05 2014 — This phase of your Medicare Part D coverage is called the Catastrophic Coverage phase and has the same cost-sharing for every Medicare Part D plan.   For generics or preferred brand drugs tha . . .

May, 04 2013 — This phase of your Medicare Part D coverage is called the Catastrophic Coverage phase and has the same cost-sharing for every Medicare Part D plan.   For generics or preferred brand drugs tha . . .